Accure Biotech Limited - Net Worth and Insider Trading

Accure Biotech Limited Net Worth

The estimated net worth of Accure Biotech Limited is at least $1.0 Billion dollars as of 2024-11-07. Accure Biotech Limited is the 2501 Other of CARsgen Therapeutics Holdings Ltd and owns about 215,123,753 shares of CARsgen Therapeutics Holdings Ltd (HKSE:02171) stock worth over $1.0 Billion. Details can be seen in Accure Biotech Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Accure Biotech Limited has not made any transactions after 2021-06-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Accure Biotech Limited

To

Accure Biotech Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Accure Biotech Limited owns 1 companies in total, including CARsgen Therapeutics Holdings Ltd (HKSE:02171) .

Click here to see the complete history of Accure Biotech Limited’s form 4 insider trades.

Insider Ownership Summary of Accure Biotech Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:02171 CARsgen Therapeutics Holdings Ltd 2021-06-18 2501 Other

Accure Biotech Limited Latest Holdings Summary

Accure Biotech Limited currently owns a total of 1 stock. Accure Biotech Limited owns 215,123,753 shares of CARsgen Therapeutics Holdings Ltd (HKSE:02171) as of June 18, 2021, with a value of $1.0 Billion.

Latest Holdings of Accure Biotech Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02171 CARsgen Therapeutics Holdings Ltd 2021-06-18 215,123,753 4.73 1,017,535,352

Holding Weightings of Accure Biotech Limited


Accure Biotech Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Accure Biotech Limited has made a total of 1 transactions in CARsgen Therapeutics Holdings Ltd (HKSE:02171) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in CARsgen Therapeutics Holdings Ltd is the sale of 215,123,753 shares on June 18, 2021, which brought Accure Biotech Limited around $0.

Insider Trading History of Accure Biotech Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Accure Biotech Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Accure Biotech Limited Ownership Network

Ownership Network List of Accure Biotech Limited

No Data

Ownership Network Relation of Accure Biotech Limited

Insider Network Chart

Accure Biotech Limited Owned Company Details

What does CARsgen Therapeutics Holdings Ltd do?

Who are the key executives at CARsgen Therapeutics Holdings Ltd?

Accure Biotech Limited is the 2501 Other of CARsgen Therapeutics Holdings Ltd. Other key executives at CARsgen Therapeutics Holdings Ltd include 2401 A concert party to an agreement to buy shares Guo Bingsen , 2101 Beneficial owner Guo Huaqing , and 2401 A concert party to an agreement to buy shares Li Zonghai .

CARsgen Therapeutics Holdings Ltd (HKSE:02171) Insider Trades Summary

Over the past 18 months, Accure Biotech Limited made no insider transaction in CARsgen Therapeutics Holdings Ltd (HKSE:02171). Other recent insider transactions involving CARsgen Therapeutics Holdings Ltd (HKSE:02171) include a net purchase of 1,369,500 shares made by Guo Huaqing , a net sale of 0 shares made by Wang Huamao , and a net sale of 0 shares made by Guo Bingsen .

In summary, during the past 3 months, insiders sold 0 shares of CARsgen Therapeutics Holdings Ltd (HKSE:02171) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CARsgen Therapeutics Holdings Ltd (HKSE:02171) were sold and 1,369,500 shares were bought by its insiders, resulting in a net purchase of 1,369,500 shares.

CARsgen Therapeutics Holdings Ltd (HKSE:02171)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CARsgen Therapeutics Holdings Ltd Insider Transactions

No Available Data

Accure Biotech Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Accure Biotech Limited. Currently GuruFocus does not have mailing address information for Accure Biotech Limited.